Approval · Notice of Compliance 31093 · 2023
DAPTOMYCIN FOR INJECTION: Notice of Compliance 31093
Issued June 27, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 31093
- Date
- June 27, 2023
- Company
- Sandoz Canada Inc.Saint-Hubert, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- Revision to the Package Insert
- Canadian reference product
- CUBICIN (Cubist Pharmaceuticals Llc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DAPTOMYCIN FOR INJECTION | Not yet assigned | — |
Medicinal ingredients
- DAPTOMYCIN 500 MG per VIAL